{"id":49,"date":"2025-02-19T16:08:21","date_gmt":"2025-02-19T16:08:21","guid":{"rendered":"https:\/\/www.convidia.de\/en\/?page_id=49"},"modified":"2025-07-17T14:00:28","modified_gmt":"2025-07-17T14:00:28","slug":"pharmacovigilance","status":"publish","type":"page","link":"https:\/\/www.convidia.de\/en\/pharmacovigilance\/","title":{"rendered":"Pharmacovigilance"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;RGBA(255,255,255,0)&#8221; background_image=&#8221;https:\/\/www.convidia.de\/en\/wp-content\/uploads\/sites\/2\/2025\/02\/banner-pharmakovigilanz.jpg&#8221; min_height=&#8221;450px&#8221; min_height_tablet=&#8221;600px&#8221; min_height_phone=&#8221;700px&#8221; min_height_last_edited=&#8221;on|phone&#8221; custom_padding=&#8221;|0px||||&#8221; border_color_all=&#8221;#FFFFFF&#8221; box_shadow_style=&#8221;preset3&#8243; box_shadow_blur=&#8221;8px&#8221; box_shadow_spread=&#8221;-9px&#8221; box_shadow_color=&#8221;#706F6F&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_3,2_3&#8243; use_custom_gutter=&#8221;on&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;30px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_button button_url=&#8221;#Literatur&#8221; button_text=&#8221;Literature Research&#8221; button_alignment=&#8221;right&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_bg_color=&#8221;rgba(112,134,147,0.6)&#8221; box_shadow_style=&#8221;preset3&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][et_pb_button button_url=&#8221;#PSUR&#8221; button_text=&#8221;PSUR \/ DSUR, RMP&#8221; button_alignment=&#8221;right&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_bg_color=&#8221;rgba(112,134,147,0.6)&#8221; box_shadow_style=&#8221;preset3&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][et_pb_button button_url=&#8221;#Vigilanz&#8221; button_text=&#8221;Vigilance for Medical Devices&#8221; button_alignment=&#8221;right&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_bg_color=&#8221;rgba(112,134,147,0.6)&#8221; box_shadow_style=&#8221;preset3&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;25px||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_blurb title=&#8221;Pharmacovigilance&#8221; content_max_width=&#8221;830px&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_level=&#8221;h1&#8243; header_font=&#8221;|&#8211;et_global_body_font_weight|||||||&#8221; body_font_size=&#8221;24px&#8221; body_line_height=&#8221;1.4em&#8221; background_layout=&#8221;dark&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;||||false|false&#8221; text_shadow_style=&#8221;preset3&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div>\n<div><span lang=\"EN-GB\">We draw up risk management plans and monitor the safety and risk-benefit profile of medicinal products and the safety of use of medical devices.<\/span><\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;|0px||||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row module_id=&#8221;Literatur&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Open Sans Light|300|||||||&#8221; header_text_align=&#8221;center&#8221; header_text_color=&#8221;#EA5B1B&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1>Literature Research<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_3,2_3&#8243; use_custom_gutter=&#8221;on&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_blurb title=&#8221;Our services in the context of literature research&#8221; content_max_width=&#8221;800px&#8221; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_level=&#8221;h2&#8243; header_font=&#8221;|600|||||||&#8221; header_text_color=&#8221;#706F6F&#8221; body_font=&#8221;||||||||&#8221; global_colors_info=&#8221;{}&#8221; header_line_height=&#8221;1.3em&#8221; url_new_window=&#8221;on&#8221; custom_margin=&#8221;3px||||false|false&#8221;]<\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span>Definition of the study objectives<\/span><\/li>\n<li style=\"font-weight: 400;\"><span>Selection of suitable data sources<\/span><\/li>\n<li style=\"font-weight: 400;\"><span>Review and evaluation of available data<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Documentation of the research<\/span><\/li>\n<\/ul>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_blurb title=&#8221;Use of meaningful data from the published literature&#8221; content_max_width=&#8221;800px&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;&#8211;et_global_body_font|500|||||||&#8221; header_text_color=&#8221;#706F6F&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;Open Sans Regular||||||||&#8221; custom_padding=&#8221;||20px||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p style=\"font-weight: 400;\"><span>The targeted use of a literature search in the context of scientific studies offers an efficient way of accessing a comprehensive and differentiated database. Even before the start of the study, a thorough literature search helps to evaluate the relevant key points of the study design and create a sound basis for decision-making.<\/span><\/p>\n<p style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Depending on the product and the planned approval strategy, the scope of own clinical studies can be reduced by demonstrating the efficacy of an active substance or a form of therapy by referring to existing data from the scientific literature. <\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row module_id=&#8221;PSUR&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||10px||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/www.convidia.de\/en\/wp-content\/uploads\/sites\/2\/2025\/02\/Divider.jpg&#8221; title_text=&#8221;Divider&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; transform_scale=&#8221;102%|102%&#8221; transform_scale_tablet=&#8221;102%|102%&#8221; transform_scale_phone=&#8221;202%|202%&#8221; transform_scale_last_edited=&#8221;on|phone&#8221; transform_translate_tablet=&#8221;&#8221; transform_translate_phone=&#8221;&#8221; transform_translate_last_edited=&#8221;on|desktop&#8221; transform_rotate_tablet=&#8221;&#8221; transform_rotate_phone=&#8221;&#8221; transform_rotate_last_edited=&#8221;on|desktop&#8221; transform_skew_tablet=&#8221;&#8221; transform_skew_phone=&#8221;&#8221; transform_skew_last_edited=&#8221;on|desktop&#8221; transform_origin_tablet=&#8221;&#8221; transform_origin_phone=&#8221;&#8221; transform_origin_last_edited=&#8221;on|desktop&#8221; transform_styles_last_edited=&#8221;on|phone&#8221; custom_margin=&#8221;||40px||false|false&#8221; transform_styles_tablet=&#8221;&#8221; transform_styles_phone=&#8221;&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Open Sans Light|300|||||||&#8221; header_text_align=&#8221;center&#8221; header_text_color=&#8221;#EA5B1B&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1>PSUR \/ DSUR, RMP<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_3,2_3&#8243; use_custom_gutter=&#8221;on&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_blurb title=&#8221;Our services in drug safety&#8221; content_max_width=&#8221;800px&#8221; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_level=&#8221;h2&#8243; header_font=&#8221;|600|||||||&#8221; header_text_color=&#8221;#706F6F&#8221; body_font=&#8221;||||||||&#8221; global_colors_info=&#8221;{}&#8221; header_line_height=&#8221;1.3em&#8221; url_new_window=&#8221;on&#8221; custom_margin=&#8221;3px||||false|false&#8221;]<\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span>Development of RMPs<\/span><\/li>\n<li style=\"font-weight: 400;\"><span>Medical Monitoring<\/span><\/li>\n<li style=\"font-weight: 400;\"><span>Creation of DSURs during the study phases<\/span><\/li>\n<li style=\"font-weight: 400;\"><span>Creation of PSURs after successful approval<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Coding according to MedDRA, WHO-DD, WHO.ICD (incl. acquisition of the necessary licenses)<\/span><\/li>\n<\/ul>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_blurb title=&#8221;Drug safety before and after market launch&#8221; content_max_width=&#8221;800px&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;&#8211;et_global_body_font|500|||||||&#8221; header_text_color=&#8221;#706F6F&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;Open Sans Regular||||||||&#8221; custom_padding=&#8221;||20px||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p style=\"font-weight: 400;\"><span>Already during the preparation of the clinical trial, we work with you to develop risk management plans (RMPs) in accordance with the provisions of the German Medicinal Products Act (AMG). The RMPs define the key aspects of the safety profile and the most important measures to avoid known risks. We draw up detailed RMPs with extensive information, documentation and training material, which also serves as the basis for subsequent pharmacovigilance measures during the course of the study.<\/span><\/p>\n<p style=\"font-weight: 400;\"><span>We handle the pharmacovigilance notifications to the competent authorities: For medicinal products that are still in the study phase, we evaluate and develop the safety profile and prepare the regular reports for the authorities as part of DSURs (Development Safety Update Reports) in accordance with the ICH guideline.<\/span><\/p>\n<p style=\"font-weight: 400;\"><span>Following approval, we monitor the safety and risk-benefit profile of medicinal products and report adverse effects and new findings from observational studies as part of PSURs (Periodic Safety Update Reports).<\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row module_id=&#8221;Vigilanz&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||10px||false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/www.convidia.de\/en\/wp-content\/uploads\/sites\/2\/2025\/02\/Divider.jpg&#8221; title_text=&#8221;Divider&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; transform_scale=&#8221;102%|102%&#8221; transform_scale_tablet=&#8221;102%|102%&#8221; transform_scale_phone=&#8221;202%|202%&#8221; transform_scale_last_edited=&#8221;on|phone&#8221; transform_translate_tablet=&#8221;&#8221; transform_translate_phone=&#8221;&#8221; transform_translate_last_edited=&#8221;on|desktop&#8221; transform_rotate_tablet=&#8221;&#8221; transform_rotate_phone=&#8221;&#8221; transform_rotate_last_edited=&#8221;on|desktop&#8221; transform_skew_tablet=&#8221;&#8221; transform_skew_phone=&#8221;&#8221; transform_skew_last_edited=&#8221;on|desktop&#8221; transform_origin_tablet=&#8221;&#8221; transform_origin_phone=&#8221;&#8221; transform_origin_last_edited=&#8221;on|desktop&#8221; transform_styles_last_edited=&#8221;on|phone&#8221; custom_margin=&#8221;||40px||false|false&#8221; transform_styles_tablet=&#8221;&#8221; transform_styles_phone=&#8221;&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Open Sans Light|300|||||||&#8221; header_text_align=&#8221;center&#8221; header_text_color=&#8221;#EA5B1B&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1>Vigilance for Medical Devices<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_3,2_3&#8243; use_custom_gutter=&#8221;on&#8221; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_blurb title=&#8221;Our services to support the vigilance system &#8221; content_max_width=&#8221;800px&#8221; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_level=&#8221;h2&#8243; header_font=&#8221;|600|||||||&#8221; header_text_color=&#8221;#706F6F&#8221; body_font=&#8221;||||||||&#8221; global_colors_info=&#8221;{}&#8221; header_line_height=&#8221;1.3em&#8221; url_new_window=&#8221;on&#8221; custom_margin=&#8221;3px||||false|false&#8221;]<\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span>Structure of the eCRF for recording reportable events <\/span><\/li>\n<li style=\"font-weight: 400;\"><span>Compliance with deadlines<\/span><\/li>\n<li style=\"font-weight: 400;\"><span>Development and regular update of the RMP<\/span><\/li>\n<\/ul>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_blurb title=&#8221;A critical look at application security &#8221; content_max_width=&#8221;800px&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;&#8211;et_global_body_font|500|||||||&#8221; header_text_color=&#8221;#706F6F&#8221; header_line_height=&#8221;1.3em&#8221; body_font=&#8221;Open Sans Regular||||||||&#8221; custom_padding=&#8221;||20px||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p style=\"font-weight: 400;\"><span>Depending on the risk profile, the safety of use of medical devices is monitored as strictly as for medicinal products. The vigilance systems prescribed in the MDR (MDR Art. 87 &#8211; 92) compile all relevant information, including from complaint processing, user reports and market surveillance. They define rules and specifications for evaluation and reporting to the competent authorities.<\/span><\/p>\n<p style=\"font-weight: 400;\"><span>We establish carefully documented, MDR-compliant vigilance systems with clearly defined specifications for possible adverse events. It goes without saying that we also take care of timely regulatory reporting in accordance with national, European and international requirements.<\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#708693&#8243; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px||10px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_3,1_3,1_3&#8243; use_custom_gutter=&#8221;on&#8221; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_module=&#8221;188&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Open Sans Regular|500|||||||&#8221; header_text_color=&#8221;#F9B233&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1>Contact<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>We are happy to be there for you personally: Talk to us if you have any questions about us and our services!<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>We are also always happy to have nice conversations at congresses:<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjU4In19@&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;Our congress dates&#8221; _builder_version=&#8221;4.27.4&#8243; _dynamic_attributes=&#8221;button_url&#8221; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_bg_color=&#8221;#F9B233&#8243; button_border_width=&#8221;1px&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.24.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>CONVIDIA clinical research GmbH<br \/>Urbanstra\u00dfe 8<br \/>48143 M\u00fcnster, Germany<\/p>\n<p>Phone: +49 (0)251 &#8211; 21 401 30<br \/><span style=\"color: #ff9900;\"><a href=\"mailto:contact[a]convidia.de\" style=\"color: #ff9900;\">contact@convidia.de<\/a><\/span><\/p>\n<p><span style=\"color: #ff9900;\"><\/span><\/p>\n<p><span style=\"color: #ff9900;\"><a href=\"\/en\/contact\/#impressum\" style=\"color: #ff9900;\">Imprint<\/a> \u00b7 <a href=\"\/en\/Contact\/#Datenschutz\" style=\"color: #ff9900;\">Data Protection<\/a><\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We draw up risk management plans and monitor the safety and risk-benefit profile of medicinal products and the safety of use of medical devices. &nbsp;Literature Research Definition of the study objectives Selection of suitable data sources Review and evaluation of available data Documentation of the research The targeted use of a literature search in the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-49","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.convidia.de\/en\/wp-json\/wp\/v2\/pages\/49","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.convidia.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.convidia.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.convidia.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.convidia.de\/en\/wp-json\/wp\/v2\/comments?post=49"}],"version-history":[{"count":16,"href":"https:\/\/www.convidia.de\/en\/wp-json\/wp\/v2\/pages\/49\/revisions"}],"predecessor-version":[{"id":305,"href":"https:\/\/www.convidia.de\/en\/wp-json\/wp\/v2\/pages\/49\/revisions\/305"}],"wp:attachment":[{"href":"https:\/\/www.convidia.de\/en\/wp-json\/wp\/v2\/media?parent=49"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}